MLEC
Moolec Science SA Ordinary Shares
NASDAQ: MLEC · HEALTHCARE · BIOTECHNOLOGY
$11.25
+25.14% today
Updated 2026-04-30
Market cap
$5.87M
P/E ratio
—
P/S ratio
0.01x
EPS (TTM)
$-258.69
Dividend yield
—
52W range
$3 – $157
Volume
0.4M
Moolec Science SA Ordinary Shares (MLEC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-174.70%
ROA
-21.70%
Debt/equity
-3.74x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | — | $-13802.00 | — | — | — |
| 2022 | $0.00 | $-4.53M | — | — | — |
| 2023 | $905049.00 | $-51.79M | -15.83% | -735.19% | -5,722.22% |
| 2024 | $5.63M | $-7.31M | 8.40% | -160.76% | -129.99% |
| 2025 | $333.61M | $-111.46M | 34.17% | -3.14% | -33.41% |